Phase III, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study to evaluate the efficacy and safety of tirbanibulin 10 mg/g ointment applied to a treatment field greater than 25 cm² and up to

CLINICAL TRIAL WITH MEDICINES